Julieann Sludden
- Molecular Biology top 10%
- Oncology top 10%
- Cancer Research
- Pathology and Forensic Medicine top 10%
- Biomaterials top 10%
- Co-authors
- Robert BrownStanley B. KayeGordon StrathdeeJane A. PlumbAlan V. BoddyDavid JamiesonAlexander I. GrayIjeoma F. Uchegbu
- Topics
- Cancer therapeutics and mechanisms (5 papers)Acute Lymphoblastic Leukemia research (4 papers)DNA Repair Mechanisms (3 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Julieann Sludden
19 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 760
- Oncology 453
- Cancer Research 138
- Pathology and Forensic Medicine 118
- Biomaterials 114
Countries citing papers authored by Julieann Sludden
This map shows the geographic impact of Julieann Sludden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julieann Sludden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julieann Sludden more than expected).
Fields of papers citing papers by Julieann Sludden
This network shows the impact of papers produced by Julieann Sludden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julieann Sludden. The network helps show where Julieann Sludden may publish in the future.
Co-authorship network of co-authors of Julieann Sludden
This figure shows the co-authorship network connecting the top 25 collaborators of Julieann Sludden. A scholar is included among the top collaborators of Julieann Sludden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julieann Sludden. Julieann Sludden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 19 | |
| 3 | 4 | |
| 4 | 6 | |
| 5 | 126 | |
| 6 | 50 | |
| 7 | 66 | |
| 8 | 30 | |
| 9 | 97 | |
| 10 | 22 | |
| 11 | 84 | |
| 12 | 19 | |
| 13 | 5 | |
| 14 | 26 | |
| 15 | Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter. | 390 |
| 16 | 96 | |
| 17 | 9 | |
| 18 | 105 | |
| 19 | 22 |
About Julieann Sludden
Julieann Sludden is a scholar working on Structural Biology, Oncology and Genetics, having authored 19 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and DNA Repair Mechanisms (3 papers). The work is most often cited by research in Oncology (453 citations), Molecular Biology (760 citations) and Cancer Research (138 citations). Julieann Sludden has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Robert Brown, Stanley B. Kaye, Gordon Strathdee, Jane A. Plumb, Alan V. Boddy, David Jamieson, Alexander I. Gray, Ijeoma F. Uchegbu, Ruth Plummer and Andreas G. Schätzlein. Their work appears in journals such as Clinical Cancer Research, British Journal of Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.